NCT03616392View on ClinicalTrials.gov

Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 25, 2018

Primary Completion Date

September 17, 2018

Study Completion Date

November 13, 2018

Conditions
Diabetes Mellitus, Type II
Interventions
DRUG

D308, CKD-501

"1. D308~2. CKD-501: Lobeglitazone sulfate 0.5mg"

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY